Influence of diagnostic and treatment factors in the population pharmacokinetics of gentamicin

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 2, 1998, Pages 141-148

  Romano, S ^a   Gonzalez P ^b   Tejada, P ^b   Anton J ^b   Aguado, J M ^c   Lanao, J M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Hospital Campo Aranuelo   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CANCER; COMPUTER PROGRAM; DOSE TIME EFFECT RELATION; DOSIMETRY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POPULATION DYNAMICS; POPULATION MODEL; RETROSPECTIVE STUDY;

ABSCESS; ADULT; APPENDICITIS; CHOLECYSTITIS; COLONIC NEOPLASMS; DRUG INTERACTIONS; FEMALE; GENTAMICINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERITONITIS; PNEUMONIA; RETROSPECTIVE STUDIES;

EID: 0031689354     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00150.x     Document Type: Article

References (32)

1. Garrison MW, Zaske DE, Rotschaffer JC. (1990) Aminoglycosides: another perspective. DICP the Annals of Pharmacotherapy, 24, 267-272.
2. Barriere SL. (1988) Aminoglycosides: A reassessment of their therapeutic role. Clinical Pharmacy, 7, 385-387.
3. Moore RD, Smith CR, Lietman PS. (1984) The association of aminoglycoside plasma levels with mortality in patients with Gram-negative bacteremia. Journal of Infectious Diseases, 149, 443-448.
4. Chelluri L, Jastremski S. (1987) Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Critical Care Medicine, 15, 1143-1145.
5. Siber GR, Echeverria P, Smith AL, et al. (1975) Pharmacokinetics of gentamicin in children and adults. Journal of Infectious Diseases, 132, 637-651.
6. Zaske DE, Sawchuk RJ, Gerding DW, et al. (1976) Increased dosage requirements of gentamicin in burn patients. Journal of Trauma, 16, 824-828.
7. Schwartz SW, Pazin GJ, Lyon JA, et al. (1978). A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. Journal of Infections Disease, 138, 499-505.
8. Gill MA, Kern JW. (1979) Altered gentamicin distribution in ascitic patients. American Journal of Hospital Pharmacy, 36, 1704-1706.
9. Kearns GL, Hilman BC, Wilson JT. (1982). Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. Journal of Pediatrics, 100, 412-418.
10. Kloth DD, Tegtmeier BR, Kong C, et al. (1985) Altered gentamicin pharmacokinetics during the perioperative period. Clinical Pharmacy, 4, 182-185.
11. Lanao JM, Berrocal A, Calvo MV, et al. (1989) Population pharmacokinetic study of gentamicin and a Bayesian approach in patients with renal impairment. Journal of Clinical Pharmacy and Therapeutics, 14, 213-223.
12. Etzel JV, Nafziger A, Bertino J. (1992) Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia. Antimicrobial Agents and Chemotherapy, 36, 679-681.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. (1981). Apache II a severity of disease classification system. Critical Care Medicine, 13, 818-829.
14. Cockcroft DW, Gault MH. (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-41.
15. Beal SL, Sheiner LB. (1989) NONMEM user's guides. San Francisco, CA: NONMEM Project Group. University of California.
16. Sheiner LB, Rosenberg B, Marathe VV. (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics, 5, 445-479.
17. Yamaoka K, Nakagawa T, Uno T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.
18. Dager W. (1994) Aminoglycoside pharmacokinetics: volume of distribution in specific adult patients subgroups. Annals of Pharmacotherapy, 28, 944-951.
19. Townsend PL, Fink MP, Stein KL, Murphy SG. (1989) Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients. Critical Care Medicine, 17, 154-157.
20. Mann HJ, Fuhs DN, Awang R, Ndemo FA, Cerra FB. (1987) Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clinical Pharmacy, 6, 148-153.
21. Oparaoji EC, Cornwell EE, Hekmat E, et al. (1992) Aminoglycoside volume of distribution in postoperative patients with septic shock. Clinical Pharmacy, 12, 131-134.
22. Gardner DK, Schneider PJ. (1984) Gentamicin dosage requirement in post-partum patients. Clinical Pharmacy, 3, 416-418.
23. Carr MR, Dick SP, Bordley J, Bertino JS. (1988). Gentamicin dosage requirements in patients with acute pancreatitis. Surgery, 103, 533-537.
24. Katz RB, Lawson LA, Johnson NE, Schechter LN. (1993) Aminoglycoside pharmacokinetics in patients with AIDS. Journal of Pharmaceutical Technology, 9, 14-17.
25. Bertino JS, Booker LA, Franck P, Rybicki B. (1991) Gentamicin pharmacokinetics in patients with malignancies. Antimicrobial Agents and Chemotherapy, 35, 1501-1503.
26. Higa G, Murray W. (1987) Alterations in aminoglycoside pharmacokinetics in patients with cancer. Clinical Pharmacy, 6, 963-966.
27. Mc. Guire WM, Ament PW. (1977) Creating a community hospital-based aminoglycoside dosing nomogram. Formulary, 32, 1056-1065.
28. Schentag JJ, Jusko WJ, Vance JW, et al. (1977). Gentamicin disposition and tissue accumulation on multiple dosing. Journal of Pharmacokinetics and Biopharmaceutics, 5, 559-578.
29. Reeves DS, Mac Gowan AP. (1993) Once-daily aminoglycoside dosing. Lancet, 341, 895-896.
30. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. (1997). Once-daily dosing of aninoglycosides: review and recommendations for clinical practice. Journal of Antimicrobial Chemotherapy, 39, 677-686.
31. Begg EJ, Barclay ML, Dufull SB. (1995). A suggested approach to once-daily aminoglycoside dosing. British Journal of Clinical Pharmacology, 39, 605-609.
32. Barclay ML, Duffull SB, Begg EJ, Buttimore RC. (1995). Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve. Australian and New Zealand Journal of Medicine, 25, 230-235.